IMC Chicago’s inTEST INTT Stock Holding History

IMC Chicago’s Portfolio INTT Stock Details INTT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$198K	Buy	10,900 +700	+7%	+$11.8K	﹤0.01%	5692
2026 Q1	$139K	Buy	+10,200	New	+$112K	﹤0.01%	5218

Other funds holding INTT

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return

IMC Chicago's INTT Position: Q2 2026 in Review

IMC Chicago increased its inTEST (INTT) stake by 1.6% in Q2 2026, buying an estimated $4.13K and bringing the position to 15,374 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #5297.

IMC Chicago first reported a position in INTT in Q1 2026 and has held it in 2 quarters since. 90 funds tracked by Wall St. Rank hold INTT as of Q2 2026.

IMC Chicago held 15,374 shares of inTEST worth $279K as of Q2 2026.
IMC Chicago bought 244 inTEST shares in Q2 2026, an estimated $4.13K.
inTEST made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5297 holding.
IMC Chicago first reported a position in inTEST in Q1 2026 and has held it in 2 quarters since.
90 funds tracked by Wall St. Rank held inTEST as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.